tiprankstipranks
Trending News
More News >
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
US Market

Quoin Pharmaceuticals (QNRX) Stock Forecast & Price Target

Compare
331 Followers
See the Price Targets and Ratings of:

QNRX Financial Forecast

QNRX Earnings Forecast

Next quarter’s earnings estimate for QNRX is -$6.83 with a range of -$6.83 to -$6.83. The previous quarter’s EPS was -$6.50. QNRX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.67% of the time in the same period. In the last calendar year QNRX has Preformed in-line its overall industry.
Next quarter’s earnings estimate for QNRX is -$6.83 with a range of -$6.83 to -$6.83. The previous quarter’s EPS was -$6.50. QNRX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.67% of the time in the same period. In the last calendar year QNRX has Preformed in-line its overall industry.
No data currently available

QNRX Sales Forecast

Next quarter’s sales forecast for QNRX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. QNRX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 39.91% of the time in the same period. In the last calendar year QNRX has Preformed in-line its overall industry.
Next quarter’s sales forecast for QNRX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. QNRX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 39.91% of the time in the same period. In the last calendar year QNRX has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on QNRX
Naz RahmanMaxim Group
Maxim Group
$70
Buy
655.12%
Upside
Reiterated
03/13/25
Buy Rating for Quoin Pharmaceuticals: Promising Phase 3 Trials and Strong Financial Position
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on QNRX
Naz RahmanMaxim Group
Maxim Group
$70
Buy
655.12%
Upside
Reiterated
03/13/25
Buy Rating for Quoin Pharmaceuticals: Promising Phase 3 Trials and Strong Financial Position
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Quoin Pharmaceuticals

1 Month
xxx
Success Rate
3/20 ratings generated profit
15%
Average Return
-16.93%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 15.00% of your transactions generating a profit, with an average return of -16.93% per trade.
3 Months
xxx
Success Rate
1/20 ratings generated profit
5%
Average Return
-38.84%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 5.00% of your transactions generating a profit, with an average return of -38.84% per trade.
1 Year
Naz RahmanMaxim Group
Success Rate
0/20 ratings generated profit
0%
Average Return
-74.61%
reiterated a buy rating 4 months ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -74.61% per trade.
2 Years
xxx
Success Rate
0/20 ratings generated profit
0%
Average Return
-81.50%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -81.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QNRX Analyst Recommendation Trends

Rating
Aug 24
Nov 24
Jan 25
Feb 25
Mar 25
Strong Buy
2
3
4
4
4
Buy
1
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
4
4
4
In the current month, QNRX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QNRX average Analyst price target in the past 3 months is 70.00.
Each month's total comprises the sum of three months' worth of ratings.

QNRX Stock Forecast FAQ

What is QNRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Quoin Pharmaceuticals’s 12-month average price target is 70.00.
    What is QNRX’s upside potential, based on the analysts’ average price target?
    Quoin Pharmaceuticals has 655.12% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is QNRX a Buy, Sell or Hold?
          Quoin Pharmaceuticals has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Quoin Pharmaceuticals’s price target?
            The average price target for Quoin Pharmaceuticals is 70.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $70.00 ,the lowest forecast is $70.00. The average price target represents 655.12% Increase from the current price of $9.27.
              What do analysts say about Quoin Pharmaceuticals?
              Quoin Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of QNRX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis